Cardiac rehabilitation wait times and relation to patient outcomes

BACKGROUND

Most cardiac rehabilitation (CR) associations have published guidelines recommending timely and early access.

AIM

To review the effects of early CR initiation on patient outcomes, and to describe the wait times associated with positive outcomes.

DESIGN

Studies were identified via a limited systematic search on key resource databases, including MEDLINE, EMBASE, and CINAHL. A focused Internet search was conducted with a concentrated grey literature search for evidence reports.

POPULATION

Studies which enrolled adult cardiac patients who were eligible to participate in a CR program, based on CR guidelines, were considered.

METHODS

Methodological filters limited retrieval for articles published between January 1, 2002-March 4, 2013. Two reviewers screened references which were identified by the search strategy by examining the titles and abstracts. If the abstract identified the appropriate patient group, and addressed CR wait times, the full article was obtained for inclusion consideration. Ten articles were included for review. Results were extracted from included studies, and results were synthesized narratively.

RESULTS

Early access was generally shown to be safe, and to have positive effects in terms of cardiac function and patient enrollment. Positive effects on functional capacity were shown with CR initiation within 3 months from an index event. Effects on quality of life were null in the long-term. Wait times ranged from 8.5-127.0 days. Seventeen days may be the optimal wait time to balance benefit with risk.

CONCLUSION

Timely access to cardiac rehab can achieve greater patient enrolment. Research on the effects of early access on heart healthy behaviors and mental health are needed. Evidence-based recommendations for wait times should be formulated by indication.

CLINICAL REHABILITATION IMPACT

Delays to intake should be minimized, and wait times shortened significantly, so that patients can reap the maximum benefits from CR participation.

The Canadian Heart Health Strategy and Action Plan: Cardiac rehabilitation as an exemplar of chronic disease management

BACKGROUND

In October 2006, federal funding was announced for the development of a national strategy to fight cardiovascular disease (CVD) in Canada. The comprehensive, independent, stakeholder-driven Canadian Heart Health Strategy and Action Plan (CHHS-AP) was delivered to the Minister of Health on February 24, 2009.

OBJECTIVES

The mandate of CHHS-AP Theme Working Group (TWG) 6 was to identify the optimal chronic disease management model that incorporated timely access to rehabilitation services and end-of-life planning and care. The purpose of the present paper was to provide an overview of worldwide approaches to CVD and cardiac rehabilitation (CR) strategies and recommendations for CR care in Canada, within the context of the well-known Chronic Care Model (CCM). A separate paper will address end-of-life issues in CVD.

METHODS

TWG 6 was composed of content representatives, primary care representatives and patients. Input in the area of Aboriginal and indigenous cardiovascular health was obtained through individual expert consultation. Information germane to the present paper was gathered from international literature and best practice guidelines. The CCM principles were discussed and agreed on by all. Prioritization of recommendations and overall messaging was discussed and decided on within the entire TWG. The full TWG report was presented to the CHHS-AP Steering Committee and was used to inform the recommendations of the CHHS-AP.

RESULTS

Specific actionable recommendations for CR are made in accordance with the key principles of the CCM.

CONCLUSIONS

The present CR blueprint, as part of the CHHS-AP, will be a first step toward reducing the health care burden of CVD in Canada.

Acute cardiovascular responses to leg-press resistance exercise in heart transplant recipients

BACKGROUND

Reduced skeletal muscle strength is characteristic of individuals following heart transplantation. Weight lifting exercise has been demonstrated as an effective means by which to increase muscular strength in other cardiac patients but the appropriateness of this form of exercise in heart transplant patients has not been investigated. The purpose of this study was to describe the cardiovascular responses of heart transplant patients to a single, prolonged bout of weight lifting training.

METHODS

Twenty-three heart transplant recipients were stratified into early (Early; 3 months; n=6), intermediate (Intermediate; 1-3 years; n=7) and late (Late; 5-14 years; n=10) post transplant groups and studied in four experimental conditions: supine rest, upright rest, single leg-press exercise (28 repetitions over 2 min 20 s at 50% 1 repetition maximum) and recovery. Swan-Ganz catheterization allowed measurement of right heart pressures and cardiac output by thermodilution. Systemic arterial pressures and heart rate were measured continuously using a non-invasive finger cuff.

RESULTS

Cardiac output increased by 30, 40 and 54% during exercise in Early, Intermediate and Late, respectively. Heart rate increased by 4.5% in Early compared to 11 and 16% increases in Intermediate and Late. At peak exercise, systolic blood pressures reached average values of 179+/-9, 180+/-14 and 176+/-8 mmHg in Early, Intermediate and Late, respectively. Average mean pulmonary artery pressure did not exceed 30 mmHg and average pulmonary wedge pressure did not exceed 15 mmHg in any group during the exercise.

CONCLUSIONS

These observations indicate that a lengthened set of single leg-press exercise at a moderate lifting intensity can be performed within safe and acceptable physiological limits in patients following heart transplantation. To better address the specific rehabilitation needs of heart transplant recipients, future research should focus on developing training programs which include weight lifting exercise.

Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction

OBJECTIVES

The aim of this study was to evaluate the impact of smoking in patients with left ventricular dysfunction.

BACKGROUND

The impact of smoking in patients with left ventricular dysfunction has not been well-studied.

METHODS

We compared the incidence of death, hospitalization due to heart failure and myocardial infarction (MI) in current smokers to ex-smokers of < or =2 years and ex-smokers of >2 years duration to never-smokers among participants of the Study Of Left Ventricular Dysfunction (SOLVD) Prevention and Intervention trials. Participants all had left ventricular ejection fraction (LVEF) <35% and follow-up was over a mean of 41 months.

RESULTS

Complete smoking status and outcome data were available in 6,704 subjects. There were 1,562 current smokers, 1,317 ex-smokers of < or =2 years, 2,354 ex-smokers of >2 years and 1,471 never-smokers. After adjusting for baseline differences of age, LVEF, race and etiology of heart failure, current smoking was associated with a significantly increased all-cause mortality (relative risk [RR]: 1.41, 95% confidence interval [CI]: 1.25 to 1.58, p < 0.001) compared with ex-smokers and never-smokers. The incidence of death or recurrent congestive heart failure requiring hospitalization or MI was significantly greater (RR: 1.39, 95% CI: 1.26 to 1.52, p < 0.001) in current smokers compared with ex-smokers and never-smokers. There were no significant differences in the number of deaths or hospitalizations due to heart failure between ex-smokers and never-smokers. This effect was consistent across both the SOLVD Prevention and Treatment trials.

CONCLUSIONS

Current smoking is a powerful independent predictor of morbidity (recurrent heart failure and MI) and mortality in patients with left ventricular dysfunction. Quitting smoking appears to have a substantial and early effect (within two years) on decreasing morbidity and mortality in patients with left ventricular dysfunction, which is at least as large as proven drug treatments recommended in patients with left ventricular dysfunction.

Changes in exercise capacity and lipids after clinic versus home-based aerobic training in coronary artery bypass graft surgery patients

PURPOSE

Despite the documented benefits of participating in rehabilitation programs, access to cardiac rehabilitation is limited for a large number of people with coronary artery disease (CAD). There is potential to increase participation in exercise training if home-based exercise were a viable option.

METHODS

We conducted a retrospective database review of 1,042 patients who took part in exercise rehabilitation following coronary artery bypass graft surgery (CABGS) between 1992 and 1998. Of these, 713 patients took part in supervised exercise, and 329 were in an unsupervised, home-based group. All exercise protocols were based upon American College of Sports Medicine guidelines, and patients in both groups received exercise prescriptions that were similar in intensity, frequency, and duration.

RESULTS

There were no differences between groups at baseline. Following 6 months of exercise training, there were substantial improvements in peak VO2, peak workload, and peak MET levels in both the supervised and unsupervised groups (P < 0.0001). Patients in the supervised group had significant improvements in both LDL and HDL-cholesterol, whereas the home-based group showed improvement in HDL-cholesterol only. When analyzed by sex, men performed better than women for all measures of exercise capacity; however, women in both groups showed approximate 20% improvements (P < 0.05) in exercise capacity as well as improvements in HDL-cholesterol.

CONCLUSION

Stable post CABGS patients who receive a detailed exercise prescription to follow at home do as well as those in supervised rehabilitation.

QT dispersion: an electrocardiographic derivative of QT prolongation

BACKGROUND

QT dispersion has been considered a surrogate for heterogeneity of repolarization, leading to ventricular arrhythmias.

METHODS

High-resolution 12-lead electrocardiograms were obtained in 15 patients with a history of ventricular tachycardia or ventricular fibrillation, 15 patients with congestive heart failure, 17 patients with a history of previous Q-wave myocardial infarction without heart failure, and 23 healthy control subjects.

RESULTS

QTc dispersion was prolonged in all 3 patient groups compared with controls (71+/-22, 68 +/-31, 61+/-27 vs 44+/-17 msec, P =. 003), but no difference was seen between heart disease groups. QTc dispersion was strongly correlated with the QTc max (r = 0.73, P<.0001) but did not correlate with the QTc min (r = 0.04, P =.76). QTc dispersion also strongly correlated with the JTc max (r = 0.54, P<.0001) but did not correlate with JTc min (r = -0.007, P =.95). QTc dispersion correlated inversely with T-wave amplitude (r = -0.35, P =.003). When all 876 electrocardiographic signals were considered, a significant negative correlation was present between QTc duration and T-wave amplitude (r = -0.133, P =.0002). Logistic regression analysis failed to demonstrate any independent risk factors that predicted ventricular arrhythmias, including all measures of dispersion.

CONCLUSIONS

The measurement of QT dispersion is strongly influenced by the maximum QT interval, as well as by changes in T-wave amplitude. QT "dispersion" may represent a summary of these changes that reflect the underlying myocardial process but does not represent an accurate quantitative measure of heterogeneity of refractoriness.

Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure

AIMS

In addition to diabetes mellitus, less severe abnormalities of glucose and insulin metabolism may be related to functional status in patients with heart failure. We examined the relationship of hyperglycaemia (> or =6.1 mmol. l(-1)) and hyperinsulinaemia (> or =11.2 mU. l(-1)) to functional status and cardiac function in patients with heart failure.

METHODS AND RESULTS

Fasting plasma glucose and insulin levels were obtained in 663 heart failure patients. The average left ventricular ejection fraction was 0.28+/-0.07, 63% were in New York Heart Association Functional Class (NYHA-FC) I/II and 37% were in NYHA-FC III/IV. Twenty seven percent had diabetes mellitus, but an additional 8% had undiagnosed diabetes mellitus (glucose > or =7 mmol. l(-1)) and 9% had glucose levels between 6.1 and 7 mmol. l(-1), so that a total of 43% (287) of patients had elevated glucose levels (> or =6.1 mmol. l(-1)). In general, more diabetic patients had NYHA-FC III/IV symptoms, shorter 6 min walk distances, but similar left ventricular ejection fractions compared to non-diabetic patients. The non-diabetic patients in NYHA-FC III/IV had higher glucose and insulin levels than patients in NYHA-FC I/II (6.3+/-0.2 vs 5.6+/-0.1 mmol. l(-1), P<0.001 and 19.6+/-2.3 vs 10. 2+/-0.6 mU. l(-1), P<0.001). Non-diabetic patients with elevated glucose levels had shorter 6 min walk distances compared to those with normal glucose levels (368.2+/-8 m vs 389.+/-4 m, P=0.02), however, left ventricular ejection fraction was similar.

CONCLUSION

Glucose abnormalities are extremely common in heart failure patients (43% of patients). Diabetes mellitus and hyperglycaemia or hyperlinsulinaemia in non-diabetic patients were related to worse symptomatic status but not worsening left ventricular ejection fraction compared to patients with normal glucose and insulin levels.

Clinical workload decreases the level of aerobic fitness in housestaff physicians

PURPOSE

To examine the relationship between clinical workload and aerobic fitness.

METHODS

Twenty healthy intern and resident volunteers were studied in a cross over manner to compare their aerobic fitness after a 1 month "easy" clinical rotation (ECR) to that after a 1 month "hard" clinical rotation (HCR). The ECR and HCR were prospectively estimated as requiring <60 (ECR) and >70 (HCR) total hours per week of hospital work respectively. Aerobic fitness was determined by directly measuring peak oxygen uptake (peakVO2) during peak cycle exercise testing after each rotation. Clinical workload for the month preceding the exercise test was estimated by documenting the amount of hospital work and sleep lost because of on-call duties. The average weekly amount of effective aerobic training for each rotation was also documented.

RESULTS

Trainees had a 206.4 (P = 0.0019, 95% CI 94-318.8) mL/min or 3 mL/kg/min (P = 0.0019, 95% CI 1.5-4.4) improvement of peakVO2 after the ECR compared with the HCR. Trainees averaged 1 (95% CI 0.16-1.81) less hour per week of exercise training, 34.1 more hours per week of hospital work (95% CI 23.0-45.3, P < 0.0001) and lost 19.1 hours more sleep per month (95% CI 11.8-26.4, p < 0.0001) during the HCR compared with the ECR. There was no correlation between changes in peakVO2 and changes in exercise training between the two rotations.

CONCLUSION

Clinical workload seems to adversely affect aerobic fitness independent of changes in exercise training. This supports previous less-objective survey data.

Diastolic flow across a ventricular septal defect: an invitation to a false diagnosis

A case is reported of a child with a perimembranous ventricular septal defect with extensive aneurysm formation misdiagnosed as a ruptured aneurysm of the sinus of Valsalva on the basis of a distinct diastolic jet seen on colour Doppler echocardiography. The hemodynamic explanation of this rarely recognized finding is apparent from simultaneous pressure tracings taken at the time of cardiac catheterization. Diastolic flow across a ventricular septal defect can be distinguished from a ruptured aneurysm of the sinus of Valsalva by the low velocity of the jet and its tendency to peak in late diastole.